Literature DB >> 12049335

Immunohistological analysis of mast cell numbers in the intratumoral and peritumoral regions of prostate carcinoma compared to benign prostatic hyperplasia.

Ozlem Aydin1, Duygu Dusmez, Leyla Cinel, Erdal Doruk, Arzu Kanik.   

Abstract

Recently, some studies reported the presence of mast cells in various malignancies and their role in tumor growth. The aim of the study was to determine the utility of mast cell numbers in evaluating benign and malignant prostate lesions, and to ascertain whether there are variations in the numbers of mast cells with the Gleason grade. The relationship between mast cell numbers and patient age was also investigated. Retrospectively, 104 prostate specimens were examined for the presence of mast cells. The study group consisted of 57 benign prostatic hyperplasias and 47 prostate carcinomas. The paraffin sections were stained with anti-human mast cell tryptase immunohistologically. The numbers of positively staining cells in five high-power fields were counted, and their mean was calculated. There was no relationship found between mast cell numbers and age statistically. The mean mast cell numbers of the intratumoral region were significantly different from those of the peritumoral region (p = 0.0001). While the difference between benign hyperplasia and the intratumoral region was found to be significant (p = 0.0001), no difference between hyperplasia and the peritumoral region was noted (p = 0.762). There was no statistical difference between Gleason score groups (p = 0.452), and there was no interaction between score groups and intraperitumoral regions (p = 0.355).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12049335     DOI: 10.1078/0344-0338-00253

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  7 in total

1.  Mast cell function in prostate inflammation, fibrosis, and smooth muscle cell dysfunction.

Authors:  Goutham Pattabiraman; Ashlee J Bell-Cohn; Stephen F Murphy; Daniel J Mazur; Anthony J Schaeffer; Praveen Thumbikat
Journal:  Am J Physiol Renal Physiol       Date:  2021-08-23

2.  Increased endogenous estrogen synthesis leads to the sequential induction of prostatic inflammation (prostatitis) and prostatic pre-malignancy.

Authors:  Stuart J Ellem; Hong Wang; Matti Poutanen; Gail P Risbridger
Journal:  Am J Pathol       Date:  2009-08-21       Impact factor: 4.307

3.  Fibroblast growth factor modulates mast cell recruitment in a murine model of prostate cancer.

Authors:  Roberto Ronca; Roberto Tamma; Daniela Coltrini; Simona Ruggieri; Marco Presta; Domenico Ribatti
Journal:  Oncotarget       Date:  2017-08-01

4.  Protein kinase Ds promote tumor angiogenesis through mast cell recruitment and expression of angiogenic factors in prostate cancer microenvironment.

Authors:  Wanfu Xu; Jiabi Qian; Fangyin Zeng; Songyu Li; Wenjing Guo; Liping Chen; Guihuan Li; Zhishuai Zhang; Qiming Jane Wang; Fan Deng
Journal:  J Exp Clin Cancer Res       Date:  2019-03-06

5.  Decreased number of mast cells infiltrating into needle biopsy specimens leads to a better prognosis of prostate cancer.

Authors:  N Nonomura; H Takayama; K Nishimura; D Oka; Y Nakai; M Shiba; A Tsujimura; M Nakayama; K Aozasa; A Okuyama
Journal:  Br J Cancer       Date:  2007-09-11       Impact factor: 7.640

6.  Augmented mast cell infiltration and microvessel density in prostate cancer.

Authors:  Paweł Stawerski; Małgorzata Wagrowska-Danilewicz; Olga Stasikowska-Kanicka; Elżbieta Tuka; Marian Danilewicz
Journal:  Contemp Oncol (Pozn)       Date:  2013-10-07

Review 7.  Mast cells as a potential prognostic marker in prostate cancer.

Authors:  Gianluigi Taverna; Guido Giusti; Mauro Seveso; Rodolfo Hurle; Piergiuseppe Colombo; Sanja Stifter; Fabio Grizzi
Journal:  Dis Markers       Date:  2013-11-11       Impact factor: 3.434

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.